Cargando…
Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991178/ https://www.ncbi.nlm.nih.gov/pubmed/32016168 http://dx.doi.org/10.1093/rap/rkz050 |
_version_ | 1783492604233515008 |
---|---|
author | Yamamura, Yuriko Matsumoto, Yoshinori Asano, Yosuke Katayama, Yu Hayashi, Keigo Ohashi, Keiji Morishita, Michiko Watanabe, Haruki Takano-Narazaki, Mariko Sada, Ken-Ei Wada, Jun |
author_facet | Yamamura, Yuriko Matsumoto, Yoshinori Asano, Yosuke Katayama, Yu Hayashi, Keigo Ohashi, Keiji Morishita, Michiko Watanabe, Haruki Takano-Narazaki, Mariko Sada, Ken-Ei Wada, Jun |
author_sort | Yamamura, Yuriko |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6991178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-69911782020-02-03 Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib Yamamura, Yuriko Matsumoto, Yoshinori Asano, Yosuke Katayama, Yu Hayashi, Keigo Ohashi, Keiji Morishita, Michiko Watanabe, Haruki Takano-Narazaki, Mariko Sada, Ken-Ei Wada, Jun Rheumatol Adv Pract Case Report Oxford University Press 2019-12-23 /pmc/articles/PMC6991178/ /pubmed/32016168 http://dx.doi.org/10.1093/rap/rkz050 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Yamamura, Yuriko Matsumoto, Yoshinori Asano, Yosuke Katayama, Yu Hayashi, Keigo Ohashi, Keiji Morishita, Michiko Watanabe, Haruki Takano-Narazaki, Mariko Sada, Ken-Ei Wada, Jun Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib |
title | Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib |
title_full | Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib |
title_fullStr | Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib |
title_full_unstemmed | Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib |
title_short | Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib |
title_sort | refractory takayasu arteritis responding to the oral janus kinase inhibitor, tofacitinib |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991178/ https://www.ncbi.nlm.nih.gov/pubmed/32016168 http://dx.doi.org/10.1093/rap/rkz050 |
work_keys_str_mv | AT yamamurayuriko refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib AT matsumotoyoshinori refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib AT asanoyosuke refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib AT katayamayu refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib AT hayashikeigo refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib AT ohashikeiji refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib AT morishitamichiko refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib AT watanabeharuki refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib AT takanonarazakimariko refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib AT sadakenei refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib AT wadajun refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib |